Article Text
Review
Rare neurological diseases: a practical approach to management
Abstract
Although neurologists are frequently faced with the management of rare diseases, there is little generic guidance for the approach to management. There are complexities with respect to diagnosis, counselling, treatment and monitoring which are idiosyncratic to rare diseases. Here we use a case report as the basis for discussion of the management of rare neurological diseases. We discuss current issues, guidance from regulatory bodies, and offer practical tips for diagnosis, treatment and monitoring, including the use of decision tree analysis. We offer a generic algorithm to aid neurologists when facing rare conditions.
- Rare Diseases
- Superficial Siderosis
- Ethics
- Diagnosis
- Medication
Statistics from Altmetric.com
Linked Articles
- Editors' Choice
Read the full text or download the PDF:
Other content recommended for you
- A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug Regulation
- Should rare diseases get special treatment?
- Rare childhood diseases: how should we respond?
- Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims data
- Rare diseases in healthcare priority setting: should rarity matter?
- Agranulocytosis with deferiprone treatment of superficial siderosis
- Orphan drugs and the NHS: should we value rarity?
- Classical infratentorial superficial siderosis of the central nervous system: pathophysiology, clinical features and management
- Rare diseases under different levels of economic analysis: current activities, challenges and perspectives
- FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis